Journal
CANCER GENE THERAPY
Volume 9, Issue 12, Pages 1062-1067Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cgt.7700548
Keywords
oncolytic; virotherapy; experimental therapeutics; cancer
Ask authors/readers for more resources
The field of replication-selective oncolytic viruses (virotherapy) has exploded over the last 10 years. As with many novel therapeutic approaches, initial overexuberance has been tempered by clinical trial results with first-generation agents. Although a number of significant hurdles to this approach have now been identified, novel solutions have been proposed and improvements are being made at a furious rate. This article seeks to initiate a discussion of these hurdles, approaches to overcome them, and unique safety and regulatory issues to consider.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available